Bone marrow is generally the dose-limiting organ of concern in radioimmunotherapy and in radionuclide palliation of bone pain. However, skeletal dosimetry is complicated by the intricate nature of its microstructure, which can vary greatly throughout skeletal regions. In this article, a new three-dimensional electron transport model for trabecular bone is introduced, based on Monte Carlo transport and on bone microstructure information for several trabecular bone sites. Methods: Marrow cavity and trabecular chord length distributions originally published by Spiers et al. were randomly sampled to create alternating regions of bone, endosteum and marrow during the three-dimensional transport of single electrons. For the marrow spaces, explici...
Calculation of the absorbed dose to active marrow is a complex problem because charged particle equi...
Objective: The aim of this study is to evaluate the effect of tissue composition on dose distributio...
Bone metastases are a very common problem in clinical oncology, affecting approximately 70% of patie...
Due to the character of the original source materials and the nature of batch digitization, quality ...
In 1995, the International Commission on Radiological Protection (ICRP) issued ICRP Publication 70 w...
-Particles are of current interest in radionuclide therapy due to their short range and high rates o...
In 1995, the International Commission on Radiological Protection (ICRP) issued ICRP Publication 70 w...
Objective of the study: to develop a skeleton model for assessing red bone marrow dose from osteotro...
Toxicity of the hematopoietically active bone marrow continues to be a primary limitation in radionu...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
Introduction One of the important applications of nuclear physics in medicine is the use of radioact...
Objective: The aim of this study is to evaluate the effect of tissue composition on dose distributi...
Calculation of the absorbed dose to active marrow is a complex problem because charged particle equi...
Objective: The aim of this study is to evaluate the effect of tissue composition on dose distributio...
Bone metastases are a very common problem in clinical oncology, affecting approximately 70% of patie...
Due to the character of the original source materials and the nature of batch digitization, quality ...
In 1995, the International Commission on Radiological Protection (ICRP) issued ICRP Publication 70 w...
-Particles are of current interest in radionuclide therapy due to their short range and high rates o...
In 1995, the International Commission on Radiological Protection (ICRP) issued ICRP Publication 70 w...
Objective of the study: to develop a skeleton model for assessing red bone marrow dose from osteotro...
Toxicity of the hematopoietically active bone marrow continues to be a primary limitation in radionu...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
The calculation of absorbed dose in skeletal tissues at radiogenic risk has been a difficult problem...
Introduction One of the important applications of nuclear physics in medicine is the use of radioact...
Objective: The aim of this study is to evaluate the effect of tissue composition on dose distributi...
Calculation of the absorbed dose to active marrow is a complex problem because charged particle equi...
Objective: The aim of this study is to evaluate the effect of tissue composition on dose distributio...
Bone metastases are a very common problem in clinical oncology, affecting approximately 70% of patie...